CASP3 and familial pancreatic carcinoma: Activity of caspase-3 was confirmed by demonstrating the cleavage of its downstream target poly (ADP)-ribose polymerase (PARP) concurrent with findings in other cancers namely, NSCLC, colonic-, breast-, and pancreatic- cancer cells [24–26].